Purified Cannabinoids Open New Opportunities in Pain Management

As more Canadians than ever suffer chronic pain, the chase is on to find novel therapeutic approaches to effectively manage their conditions. In fact, BMC Public Health estimates that 20% of adults on a global level suffer from chronic pain while 10% are newly diagnosed every year. In Canada, chronic pain affects 1.5 million people. As national and worldwide numbers in pain diagnoses continue to rise, innovators in the cannabis industry are developing promising therapies to address this growing market. InMed Pharmaceuticals, Inc. (CSE: IN) (OTC: IMLFF) (IMLFF Profile), Aurora Cannabis, Inc. (OTC: ACBFF)

...read more at https://www.prnewswire.com/news-releases/purified-cannabinoids-open-new-opportunities-in-pain-management-662052573.html